A Kenyan government task force has proposed introducing chemical castration for individuals convicted of defiling children and Persons with Disabilities, sparking mixed reactions among experts. Dr. Ahmed Ali Yousef, a consultant urologist at Aga Khan University Hospital, weighed in on the medical realities, risks, and limitations of this approach.

• Chemical castration involves using medication to reduce testosterone production, a process requiring ongoing injections every one to six months.
• The goal is to reach a "castrate level" of testosterone, significantly suppressing sexual desire and ability.
• Significant side effects include hot flashes, weight gain, loss of muscle mass, brittle bones (osteoporosis), increased risk of diabetes and heart disease, and severe depression.
• While generally reversible if injections stop, Dr. Yousef emphasizes that it disables physical ability but "does not change the driver," meaning it does not address underlying psychological issues or violent intent.
• Rigorous medical testing is crucial beforehand to prevent catastrophic health failures, as these are powerful drugs with systemic effects.